9 5 9 0 3
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.3 Breast Cancer (Dove Med Press)
- 3.4 Clin Epidemiol
- 2.5 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.5 Clin Interv Aging
- 4.7 Drug Des Dev Ther
- 2.7 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.5 Int J Women's Health
- 2.5 Neuropsych Dis Treat
- 2.7 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.3 Ther Clin Risk Manag
- 2.5 J Pain Res
- 2.8 Diabet Metab Synd Ob
- 2.8 Psychol Res Behav Ma
- 3.0 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.7 Risk Manag Healthc Policy
- 4.2 J Inflamm Res
- 2.1 Int J Gen Med
- 4.2 J Hepatocell Carcinoma
- 3.7 J Asthma Allergy
- 1.9 Clin Cosmet Investig Dermatol
- 2.7 J Multidiscip Healthc
已发表论文
通过多巴胺 (Dopamine) 氧化自聚对 MPEG-b -PCL 聚合物纳米颗粒进行表面改性以用于恶性黑色素瘤的治疗
Authors Xiong W, Peng LX, Chen HB, Li Q
Published Date April 2015 Volume 2015:10 Pages 2985—2996
DOI http://dx.doi.org/10.2147/IJN.S79605
Received 19 December 2014, Accepted 18 February 2015, Published 16 April 2015
Abstract: To enhance the therapeutic effects of chemotherapy on malignant
melanoma, paclitaxel (PTX)-loaded methoxy poly(ethylene glycol)-b -poly(ε-caprolactone)
nanoparticles (MPEG-b -PCL NPs) that
had their surfaces modified with polydopamine (PTX-loaded MPEG-b -PCL NPs@PDA) were prepared as
drug vehicles. The block copolymer MPEG-b -PCL was
synthesized by ring-opening polymerization and characterized by proton nuclear
magnetic resonance spectroscopy and gel permeation chromatography. The
PTX-loaded NPs were prepared by a modified nanoprecipitation technique. The
PTX-loaded NPs and PTX-loaded NPs@PDA were characterized in terms of size and
size distribution, zeta potential, surface morphology, drug encapsulation
efficiency, and drug release. Confocal laser scanning microscopy showed that
coumarin-6-loaded NPs@PDA could be internalized by human melanoma cell line
A875 cells. The cellular uptake efficiency of NPs was greatly enhanced
after PDA modification. The antitumor efficacy of the PTX-loaded NPs@PDA was
investigated in vitro by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and in
vivo by a xenograft tumor model. The PTX-loaded NPs@PDA could significantly
inhibit tumor growth compared to Taxol® and precursor PTX-loaded
NPs. All the results suggested that the PTX-loaded MPEG-b -PCL NPs that had their surfaces
modified with PDA are promising nanocarriers for malignant melanoma therapy.
Keywords: cancer nanotechnology, drug delivery, surface modification, polydopamine, malignant melanoma
Keywords: cancer nanotechnology, drug delivery, surface modification, polydopamine, malignant melanoma
